RecruitingPhase 3Phase 4ACTRN12609001031257
Effects of azitromycin on Hospitalized Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.
Effects of azitromycin on length of hospital stay in Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.
Sponsor
Universidade Federal do Rio Grande do Sul
Enrollment
84 participants
Start Date
Mar 10, 2009
Study Type
Interventional
Conditions
Summary
The primary purpose of the study is evaluate the efficacy of azitromycin (a drug) in infants less than 7 months of age with acute viral bronchiolitis, by reducing the length of hospital stay.
Eligibility
Sex: Both males and femalesMin Age: 10 DayssMax Age: 7 Monthss
Inclusion Criteria1
- Infants less than 7 months of age who were admitted to Hospital de Clínicas de Porto Alegre between March 2009 and July 2010 with a first episode of wheezing requiring hospitalization and supplemental oxygen, with a clinical diagnosis of bronchiolitis
Exclusion Criteria1
- Infants with cardiac, metabolic disease or clinically significant respiratory disease, such as cystic fibrosis, were not eligible, although infants with chronic neonatal lung disease associated with prematurity were included. Infants were excluded if they had received corticosteroids in any form within 7days before presentation or had received macrolides before presentation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Azitromycin - oral syrup
Dose 10mg/kg/day - oral 7 days
Azitromycin - oral syrup Dose 10mg/kg/day - oral 7 days
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609001031257